Chloroquine, or hydroxychloroquine, has been used to treat malaria since 1944. What do malaria and COVID-19 have in common? On the surface, not much. But according to early research, an old ...

Chloroquine, a drug President Donald Trump has announced is being fast-tracked for clinical testing as a treatment for COVID-19, can have deadly side effects — particularly if accidentally ...

Scientists around the world are continuing to study two drugs – chloroquine and hydroxychloroquine – for their potential as possible treatment approaches for illness caused by the novel ...

Both chloroquine and hydroxychloroquine are used to treat diseases including malaria, and have "shown activity in laboratory studies against coronaviruses, including SARS-CoV-2 (the virus that ...

Brazilian doctors stopped a test of chloroquine, a drug President Trump has promoted, after only six days because it was causing heart problems.

Chloroquine’s side effects include seizures, nausea, vomiting, deafness, vision changes and low blood pressure. Both chloroquine and hydroxychloroquine, however, are reportedly well-tolerated in ...

Chloroquine, and its derivative hydroxychloroquine, were touted by President Donald Trump as potential “game changers” when combined with azithromycin, were elevated to stardom practically ...

An employee checks the production of chloroquine phosphate, resumed after a 15-year break, in a pharmaceutical company in Nantong city in east China’s Jiangsu province on Feb. 27.

Chloroquine is dangerous when not taken under a doctor’s rigorous supervision, and its shortage can cause life-threatening consequences for lupus patients and serious health effects for ...

Of this population,1,868 patients received chloroquine, 3,783 received chloroquine with a macrolide, 3,016 received hydroxychloroquine, and 6,221 received hydroxychloroquine with a macrolide.

Didier Raoult, the French scientist whose claims for chloroquine treatment helped place it on the radars of President Trump and Dr. Oz, in a video recorded at his Marseille institute on Jan. 21.